We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-7.95%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.56B
AUM Growth
-$304M
Cap. Flow
-$67.3M
Cap. Flow %
-4.33%
Top 10 Hldgs %
82.51%
Holding
49
New
2
Increased
1
Reduced
2
Closed
4

Top Buys

Rank Stock Value
1
ARM icon
Arm
ARM
+$108M
2
NMRA icon
Neumora Therapeutics
NMRA
+$2.49M
3
DNTH icon
Dianthus Therapeutics
DNTH
+$13

Sector Composition

Rank Sector Weight
1 Technology 54.11%
2 Healthcare 39.18%
3 Industrials 6.37%
4 Consumer Staples 0.33%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PATH icon
1
UiPath
PATH
$6.61B
$241M 15.46%
14,068,674
CRWD icon
2
CrowdStrike
CRWD
$194B
$215M 13.8%
5,134,732
VERV
3
DELISTED
Verve Therapeutics
VERV
$140M 8.98%
10,549,086
GTLB icon
4
GitLab
GTLB
$5.83B
$120M 7.69%
2,647,312
PRME icon
5
Prime Medicine
PRME
$527M
$113M 7.27%
11,862,498
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
$106M 6.8%
47,675,476
ARM icon
7
Arm
ARM
$256B
$105M 6.74%
+1,960,784
New +$108M
PL icon
8
Planet Labs
PL
$7.3B
$83.1M 5.33%
31,942,641
SNOW icon
9
Snowflake
SNOW
$102B
$81.8M 5.26%
535,604
OSCR icon
10
Oscar Health
OSCR
$9.41B
$80.6M 5.18%
14,477,374
-9,565,490
-40% -$66.9M
FRSH icon
11
Freshworks
FRSH
$3.14B
$80.4M 5.16%
4,035,595
DXCM icon
12
DexCom
DXCM
$31.5B
$61.1M 3.92%
654,854
-557,952
-46% -$62.9M
DM
13
DELISTED
Desktop Metal, Inc.
DM
$16.1M 1.04%
1,104,873
RLAY icon
14
Relay Therapeutics
RLAY
$4.1B
$13.2M 0.85%
1,568,753
SANA icon
15
Sana Biotechnology
SANA
$871M
$10.9M 0.7%
2,812,500
IVVD icon
16
Invivyd
IVVD
$158M
$9.66M 0.62%
5,680,785
RAPT
17
DELISTED
RAPT Therapeutics
RAPT
$8.98M 0.58%
67,534
LYEL icon
18
Lyell Immunopharma
LYEL
$317M
$8.62M 0.55%
293,256
BEAM icon
19
Beam Therapeutics
BEAM
$2.63B
$7.73M 0.5%
321,604
ILMN icon
20
Illumina
ILMN
$31B
$7.34M 0.47%
54,967
GLUE icon
21
Monte Rosa Therapeutics
GLUE
$1.4B
$7.01M 0.45%
1,464,015
BHIL
22
DELISTED
Benson Hill, Inc.
BHIL
$5.07M 0.33%
438,636
BRNS
23
Barinthus Biotherapeutics
BRNS
$22.8M
$4.68M 0.3%
1,513,644
VERA icon
24
Vera Therapeutics
VERA
$2.3B
$4.13M 0.27%
301,580
DNTH icon
25
Dianthus Therapeutics
DNTH
$5.84B
$2.85M 0.18%
208,697
+1
+0% +$13

Similar funds

Alphabet Inc's Q3 2023 Portfolio in Review

As of Q3 2023, Alphabet Inc held 49 positions worth $1.56B, down 16% from $1.86B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Alphabet Inc withdrew a net $67.3M in Q3 2023, closing 4 positions and reducing 2 holdings. Its most notable exit was Lyft, an estimated $35.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 41% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alphabet Inc opened a new position in Arm worth $105M.

  • Alphabet Inc's largest Q3 2023 buy was Arm: 1,960,784 shares worth $105M.
  • Alphabet Inc added most to Dianthus Therapeutics in Q3 2023, an estimated $13 increase.
  • Alphabet Inc's biggest Q3 2023 reduction was Oscar Health, cutting an estimated $66.9M.
  • Alphabet Inc fully exited Lyft in Q3 2023, selling an estimated $35.5M.
  • Alphabet Inc's ten largest holdings make up 83% of its $1.56B portfolio in Q3 2023.
  • Alphabet Inc opened 2 new positions and closed 4 in Q3 2023.
  • Alphabet Inc's portfolio value fell 16% quarter-over-quarter to $1.56B.

Based on Alphabet Inc's 13F filing for Q3 2023, filed 13 Nov 2023.